JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastomaToshihiko Wakabayashi, Soichiro Shibui, Haruhiko Fukuda et al.|Journal of Neuro-Oncology|2018Cited by 65
Genetic analysis in patients with newly diagnosed glioblastomas treated with interferon-beta plus temozolomide in comparison with temozolomide aloneAtsushi Natsume, Toshihiko Wakabayashi, Kosuke Aoki et al.|Journal of Neuro-Oncology|2020Cited by 11